Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.

Proceedings of the Association of American Physicians

Volumn 108, Issue 6, 1996, Pages 444-448

  Pancake, B A ^a   Zucker Franklin, D ^a   Marmor, M ^a   Legler, P M ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; TAX PROTEIN; VIRUS DNA;

ARTICLE; GENETICS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; ISOLATION AND PURIFICATION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SOUTHERN BLOTTING; WESTERN BLOTTING;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; DNA, VIRAL; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0030279139     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)